Susan Monarez took on her new role as the 21st director of the Centers for Disease Control and Prevention (CDC) on July 31, 2023. Just shy of a month later, she was ousted from her post in a vote of no-confidence. Her departure was announced on social media by the U.S. Department of Health and Human Services. It’s the briefest stay in the agency’s 79-year history.
Monarez, 50, who was appointed acting director in January, was born into the work force. He finally got his official nomination in March. Her appointment is especially symbolic. In doing so, she made history as the first director to be Senate confirmed, following a new law passed in early 2023 allowing for the Senate confirmation. This new law sought to create a stronger, more robust vetting system for candidates who would head up the CDC.
Although her time in office was short, Monarez’s removal set off a national tsunami of resignations and retirements among high-ranking leaders in the CDC. One big name to jump was Dr. Demetre Daskalakis, who led the National Center for Immunization and Respiratory Diseases. This happened soon after her exit. Daniel Jernigan—long time director of the Center for Emerging Zoonotic Infectious Diseases—resigned during the chaos.
The announcement of Monarez’s exit came amid a growing wave of scrutiny and attacks experienced by public health officials. Dr. Daskalakis cited “the ongoing weaponization of public health” as a key reason for his resignation. Likewise, Dr. Deb Houry cited a “constant state of change” that made it impossible for her to lead in the position.
“I am not able to serve in this role any longer because of the ongoing weaponization of public health.” – Dr. Demetre Daskalakis
“Ongoing changes prevent me from continuing in my job as a leader of the agency.” – Dr. Deb Houry
“We thank her for her dedicated service to the American people.” – U.S. Department of Health and Human Services
Monarez’s removal followed a tumultuous selection process that saw former President Donald Trump abruptly withdraw his initial choice, David Weldon, leading to Monarez’s nomination. This high turnover at the CDC has raised alarm. Stability within the agency is important when public health faces such a critical moment.